期刊文献+

NSCLC恶性胸腔积液患者存活率的影响因素分析 被引量:2

Prognostic Factor Affecting Survival in NSCLC Patients with Malignant Pleural Effusions
下载PDF
导出
摘要 目的探讨非小细胞肺癌恶性胸腔积液患者存活率的影响因素。方法回顾性分析199例非小细胞肺癌恶性胸腔积液患者的临床资料,将患者年龄、性别、吸烟史、转移位点、病理形态、乳酸脱氢酶、血小板、血清C反应蛋白、顺铂胸腔内灌注这9个因素作为研究对象,采用COX多因素回归分析NSCLC恶性胸腔积液存活率的独立影响因子。结果单因素分析显示病理形态、乳酸脱氢酶、血清C反应蛋白、顺铂胸腔内灌注是患者预后影响因素,COX多因素回归分析显示血清C反应蛋白和顺铂胸腔内灌注为预后独立的影响因子。结论血清反应蛋白和顺铂胸腔内灌注为预后独立的影响因子。 Objective To investigate the factors affecting survival in non-small cell lung cancer( NSCLC) patients with malignant pleural effusion. Methods The clinical data of 199 cases of NSCLC patients with malignant pleural effusion were retrospectively analyzed. Age,gender,smoking status,metastatic sites,histopathological type,LDH,platelets,CRP,cisplatin intrathoracic perfusion were analyzed,and COX regression analysis was used to analyze the influence factors of NSCLC patients with malignant pleural effusions. Results Single factor analysis showed that pathological morphology,lactate dehydrogenase,serum CRP,and cisplatin in patients with pleural perfusion were prognostic factors,and COX regression analysis showed that CRP,cisplatin intrathoracic perfusion were independent prognostic factors. Conclusion CRP and cisplatin intrathoracic perfusion are independent prognostic factors.
出处 《实用癌症杂志》 2016年第2期246-248,共3页 The Practical Journal of Cancer
关键词 预后因素 非小细胞肺癌 恶性胸腔积液 Prognostic factor Non-small cell lung cancer(NSCLC) Malignant pleural effusions
  • 相关文献

参考文献9

  • 1杨文杰,李少娅,陈玲,等.胸腔积液CEA,LDH测定对结核性与恶性胸腔积液的鉴别诊断价值[J].大理医学院学报,2011,10(3):3941.
  • 2Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase ac- tivity in gastric cancer [J]. Cancer Res, 1995,55 ( 15 ) : 3258-3262.
  • 3陈蕾,闻平.良恶性胸腔积液实验室鉴别诊断方法进展[J].医学综述,2005,11(6):547-549. 被引量:2
  • 4Romero S, Martinez A, Hemandez L, et al. Lightscriteria re- visited consistency and comparison with new proposed alter- native criteria for separating pleural transudates from exu- dates [J]. Respiration,2013,67 ( 1 ) : 18-23.
  • 5雷振之.胸液良恶性鉴别的实验室检查新进展[J].中国实用内科杂志,2002,22(1):2-4. 被引量:26
  • 6Ynao S, Herbst RS, Shinohara H, et al. Treatment for malig- nant pleural effusion of human lung adenocarcinoma by inhi- bition of vascular endothelial growth factor receptor tyrosine kinase phosphory-lation[J]. Clin Cancer Res, 2010,6 ( 3 ) : 957.
  • 7Qureshi RA, Collinson SL, Powell ILl, et al. Management of malignant pleural effusion associated with trapped lung syn- drome [J]. Asian Cardiovasc Thorac Ann,2011,16 (2) : 120- 123.
  • 8朱中山,严文辉,杨洲,李小兵.老年非小细胞肺癌患者的预后分析[J].实用癌症杂志,2014,29(8):939-941. 被引量:4
  • 9Rahm an NM, Davies HE, Salzberg M. Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion:a phase I toxicity and dose escalation study [J]. Lancet Oncol, 2008,9(10) :946-952.

二级参考文献43

共引文献29

同被引文献17

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部